President and Chief Executive Officer
Vice President of Finance, Treasurer and Chief Financial Officer
Mr. Moody joined Nanosphere in 2007 as Chief Financial Officer and Vice President of Finance & Administration. He also serves as the Company’s Treasurer and Secretary. Mr. Moody has more than 20 years of experience in leading finance, corporate development and operations for high growth healthcare and technology companies. Previously, Mr. Moody spent six years at Medsn, a medical education company where he joined as chief financial officer and chief operating officer. Mr. Moody also served as chief financial officer and led corporate development for two private venture backed companies sold to strategic partners. Additionally, Mr. Moody provided mergers and acquisition and strategic advisory services to technology and healthcare companies for Volpe Brown Whelan & Company. Mr. Moody began his career at IBM. Mr. Moody received his B.S. from Syracuse University and his M.B.A. from the University of Chicago, Graduate School of Business.
Vice President of International Marketing and Business Development
Mark Del Vecchio
Vice President of Regulatory Affairs
Mark Del Vecchio joined Nanosphere in 2011 as Vice President of Regulatory Affairs with over 20 years of clinical and regulatory experience in the biotechnology and molecular in-vitro diagnostic (IVD) industries. Prior to coming to Nanosphere, Mr. Del Vecchio served as Vice President of Regulatory Affairs for LipoScience, Vice President of Regulatory and Clinical Affairs for Digene Corporation (now Qiagen), Director of Regulatory Affairs in the Food, Drug, Medical Device, and Agriculture practice at Hogan and Hartson, LLP, (now Hogan Lovells) and Manager of Clinical Affairs for Roche Molecular Systems. In these positions, Mr. Del Vecchio has acquired extensive experience interacting with the US Food and Drug Administration (FDA) Office of In-Vitro Diagnostic Device Evaluation and Safety (OIVD) and several international regulatory authorities, having worked predominantly with IVD’s on the leading-edge of diagnostic technology. Mr. Del Vecchio also served as Special Representative to the AdvaMed Board of Directors and as a member of the AdvaMed Diagnostic Sector Technology and Regulation Sub-committee, the Diagnostic Task Force (DTF), and the Genetics/Molecular IVD sub-committee of the DTF. Mr. Del Vecchio holds a Bachelor of Science degree in Biochemistry from the University of Scranton.